Heritage Global Partners, in partnership with Surplus Solutions, is auctioning late model R&D assets and laboratory equipment formerly operated by Atreca.
California based biopharmaceutical firm Atreca specialises in the development of novel therapeutics based on the human immune response, including cancer immunotherapy and therapeutics for autoimmune and infectious disease.
The online auction closes on the 10th of January and includes Illumina NextSeq 2000 DNA sequencer, Hamilton Vantage liquid handler, (3) Illumina MiSeq DNA sequencer, Unchained Labs Uncle protein stability screening platform, (2) Thermo Scientific Vanquish HPLC system, Beckman Coulter CytoFlex LX flor cytometer, Protein Simple Wes automated western blot system, (3) BD FACSAria Fusion flow cytometer, Kuhner ISF1-ZC stacked shaker incubators, GE Healthcare AKTA Pure 25L, (2) Applied Biosystems StepOne Plus RT-PCR, Beckman Coulter Vi-Cell BLU cell counter, (3) Biolife Solutions V-3000AB LN2 freezer, (2) IntelliCyt iQue Screener automated cell counter, (2) Thermo Scientific NanoDrop OneC, (2) Integra ViaFlo 384-channel liquid handler, Forte Bio Octed RED 96E, (2) Zeiss Axioscan Z1 autoscanner and more. The assets are located in Hayward, California and can be previewed by appointment with the auctioneer only.
Headquartered in San Diego, California Heritage Global Partners is a full service auctioneering company managing sales at all scales – from single assets through to complete turnkey facilities and factories. Heritage Global Partners works with clients across 28 different manufacturing, financial and technology industries, including the electronics, pharmaceutical, energy and food and beverage sectors.